Real-world efficacy of belimumab in systemic lupus erythematosus: a prospective cohort from a single center in China.

Yin ZhaoFumin QiJinyu BaiNa ZhangTong YangWenwen SunXin LiWei Wei

Published in: Rheumatology (Oxford, England) (2023)

Our data supported the efficacy of belimumab in Chinese SLE patients in a real-life setting. Our study also provided new evidence showing remarkable achievement of the SRI-4 response during belimumab treatment in newly diagnosed SLE patients.

Keyphrases

newly diagnosed
systemic lupus erythematosus
end stage renal disease
ejection fraction
chronic kidney disease
rheumatoid arthritis
machine learning
artificial intelligence
electronic health record
deep learning
patient reported